Market News
February 13, 2018 / 9:24 PM / a year ago

BRIEF-Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million

1 Min Read

Feb 13 (Reuters) - Bioverativ Inc:

* BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 PERFORMANCE

* Q4 REVENUE ROSE 28.3 PERCENT TO $328.7 MILLION

* QTRLY ‍SHR $1.30​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below